Oxidative damage in dengue fever

Free Radical Biology and Medicine

Volumn 47, Issue 4, 2009, Pages 375-380

  Seet, Raymond C S ^a,b   Lee, Chung Yung J ^c   Lim, Erle C H ^a,b   Quek, Amy M L ^b   Yeo, Leonard L L ^b   Huang, Shan Hong ^c   Halliwell, Barry ^c  

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Dengue; F2 isoprostanes; Free radicals; HETEs; Oxidative stress; Oxidized lipid products; Oxysterols

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ARACHIDONIC ACID; C REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL DERIVATIVE; HYDROXYICOSATETRAENOIC ACID; ISOPROSTANE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DENGUE; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHOLESTEROL; DENGUE; DENGUE VIRUS; DISEASE PROGRESSION; F2-ISOPROSTANES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 67649867918     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.04.035     Document Type: Article

References (42)

1. Vaughn D.W., Green S., Kalayanarooj S., et al. Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176 (1997) 322-330
2. Seet R.C., Ooi E.E., Wong H.B., and Paton N.I. An outbreak of primary dengue infection among migrant Chinese workers in Singapore characterized by prominent gastrointestinal symptoms and a high proportion of symptomatic cases. J. Clin. Virol. 33 (2005) 336-340
3. Seet R.C., Quek A.M., and Lim E.C. Symptoms and risk factors of ocular complications following dengue infection. J. Clin. Virol. 38 (2007) 101-105
4. Seet R.C., Quek A.M., and Lim E.C. Post-infectious fatigue syndrome in dengue infection. J. Clin. Virol. 38 (2007) 1-6
5. Lin Y.L., Liu C.C., Chuang J.I., et al. Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology 276 (2000) 114-126
6. Charnsilpa W., Takhampunya R., Endy T.P., Mammen Jr. M.P., Libraty D.H., and Ubol S. Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro. J. Med. Virol. 77 (2005) 89-95
7. Gil L., Martinez G., Tapanes R., et al. Oxidative stress in adult dengue patients. Am. J. Trop. Med. Hyg. 71 (2004) 652-657
8. Ray G., Kumar V., Kapoor A.K., Dutta A.K., and Batra S. Status of antioxidants and other biochemical abnormalities in children with dengue fever. J. Trop. Pediatr. 45 (1999) 4-7
9. Klassen P., Biesalski H.K., Mazariegos M., Solomons N.W., and Furst P. Classic dengue fever affects levels of circulating antioxidants. Nutrition 20 (2004) 542-547
10. Soundravally R., Sankar P., Bobby Z., and Hoti S.L. Oxidative stress in severe dengue viral infection: association of thrombocytopenia with lipid peroxidation. Platelets 19 (2008) 447-454
11. Soundravally R., Sankar P., Hoti S.L., Selvaraj N., Bobby Z., and Sridhar M.G. Oxidative stress induced changes in plasma protein can be a predictor of imminent severe dengue infection. Acta Trop. 106 (2008) 156-161
12. Koraka P., Murgue B., Deparis X., et al. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J. Med. Virol. 72 (2004) 445-450
13. Yen Y.T., Chen H.C., Lin Y.D., Shieh C.C., and Wu-Hsieh B.A. Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J. Virol. 82 (2008) 12312-12324
14. Halliwell B., and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 142 (2004) 231-255
15. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine, 4th edition (2007), Oxford Univ. Press, London
16. 4 poisoning. Free Radic. Biol. Med. 38 (2005) 698-710
17. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87 (1990) 9383-9387
18. Granville D.J., Tashakkor B., Takeuchi C., et al. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. Proc. Natl. Acad. Sci. USA 101 (2004) 1321-1326
19. 2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J. Biol. Chem. 281 (2006) 4616-4623
20. Wang M.H., Guan H., Nguyen X., Zand B.A., Nasjletti A., and Laniado-Schwartzman M. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am. J. Physiol. 276 (1999) F246-F253
21. Roman R.J., Renic M., Dunn K.M., Takeuchi K., and Hacein-Bey L. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm. Neurol. Res. 28 (2006) 738-749
22. Ward N.C., Puddey I.B., Hodgson J.M., Beilin L.J., and Croft K.D. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Free Radic. Biol. Med. 38 (2005) 1032-1036
23. Diczfalusy U. Analysis of cholesterol oxidation products in biological samples. J. AOAC Int. 87 (2004) 467-473
24. Bjorkhem I., and Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers?. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 734-742
25. Mol M.J., de Rijke Y.B., Demacker P.N., and Stalenhoef A.F. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 129 (1997) 169-176
26. Jacobson M.S. Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet 2 (1987) 656-658
27. Ishii K., Adachi J., Tomita M., Kurosaka M., and Ueno Y. Oxysterols as indices of oxidative stress in man after paraquat ingestion. Free Radic. Res. 36 (2002) 163-168
28. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd edition (1997), WHO, Geneva
29. Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J., and Vorndam A.V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30 (1992) 545-551
30. 2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. Free Radic. Biol. Med. 44 (2008) 1314-1322
31. Stehbens W.E. Oxidative stress in viral hepatitis and AIDS. Exp. Mol. Pathol. 77 (2004) 121-132
32. Akaike T., Noguchi Y., Ijiri S., et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93 (1996) 2448-2453
33. Chlichlia K., Los M., Schulze-Osthoff K., Gazzolo L., Schirrmacher V., and Khazaie K. Redox events in HTLV-1 Tax-induced apoptotic T-cell death. Antioxid. Redox Signal. 4 (2002) 471-477
34. 2-isoprostanes by gas chromatography-mass spectrometry. Biochem. Biophys. Res. Commun. 320 (2004) 696-702
35. Morrow J.D. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 279-286
36. Muthalif M.M., Karzoun N.A., Gaber L., et al. Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 36 (2000) 604-609
37. McGiff J.C., and Quilley J. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr. Opin. Nephrol. Hypertens. 10 (2001) 231-237
38. Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem. Biophys. Res. Commun. 254 (1999) 764-767
39. van Gorp E.C., Suharti C., Mairuhu A.T., et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin. Infect. Dis. 34 (2002) 1150-1153
40. Walzem R.L., Watkins S., Frankel E.N., Hansen R.J., and German J.B. Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease. Proc. Natl. Acad. Sci. USA 92 (1995) 7460-7464
41. Fink J., Gu F., and Vasudevan S.G. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev. Med. Virol. 16 (2006) 263-275
42. Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr. Rev. 57 (1999) 104-113